InspireMD, Inc. Series B Warrants
NSPRZ
NSPRZ was delisted on the 14th of March, 2022.
0 hedge funds and large institutions have $0 invested in InspireMD, Inc. Series B Warrants in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $5K → $0 (-$5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| – | -$3K | -41,152 | Closed |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$2K | -20,620 | Closed |
|
NSPRZ Hedge Fund Activity: Q1 2022 in Review
0 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q1 2022, worth a combined $0 — down 100% from $5K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NSPRZ and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Virtu Financial, exiting entirely with an estimated $3K sold.
- 0 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q1 2022, down from 2 in Q4 2021.
- Funds reported $0 of InspireMD, Inc. Series B Warrants stock for Q1 2022, down 100% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q1 2022 and 2 closed out, a net change of -2 holders.
- The largest InspireMD, Inc. Series B Warrants seller in Q1 2022 was Virtu Financial, an estimated $3K sold.
Based on aggregated 13F filings for Q1 2022.